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ABSTRACT The interaction of the major acidic bovine seminal plasma protein, PDC-109, with dimyristoylphosphatidylcho-
line (DMPC) membranes has been investigated by spin-label electron spin resonance spectroscopy. Studies employing
phosphatidylcholine spin labels, bearing the spin labels at different positions along the sn-2 acyl chain indicate that the protein
penetrates into the hydrophobic interior of the membrane and interacts with the lipid acyl chains up to the 14th C atom.
Binding of PDC-109 at high protein/lipid ratios (PDC-109:DMPC  1:2, w/w) results in a considerable decrease in the chain
segmental mobility of the lipid as seen by spin-label electron spin resonance spectroscopy. A further interesting new
observation is that, at high concentrations, PDC-109 is capable of (partially) solubilizing DMPC bilayers. The selectivity of
PDC-109 in its interaction with membrane lipids was investigated by using different spin-labeled phospholipid and steroid
probes in the DMPC host membrane. These studies indicate that the protein exhibits highest selectivity for the choline
phospholipids phosphatidylcholine and sphingomyelin under physiological conditions of pH and ionic strength. The selectivity
for different lipids is in the following order: phosphatidylcholine  sphingomyelin  phosphatidic acid (pH 6.0)  phosphati-
dylglycerol  phosphatidylserine  androstanol  phosphatidylethanolamine  N-acyl phosphatidylethanolamine  cho-
lestane. Thus, the lipids bearing the phosphocholine moiety in the headgroup are clearly the lipids most strongly recognized
by PDC-109. However, these studies demonstrate that this protein also recognizes other lipids such as phosphatidylglycerol
and the sterol androstanol, albeit with somewhat reduced affinity.
INTRODUCTION
The seminal plasma of mammals contains a group of acidic
proteins that bind to the spermatozoa. These proteins in the
bovine seminal plasma have been purified and are biochem-
ically well characterized. There are four proteins, which are
named BSP-A1, BSP-A2, BSP-A3, and BSP-30-kDa pro-
teins (Manjunath and Sairam, 1987; Manjunath et al., 1987).
The first three are roughly of the same molecular mass
(between 13 and 16 kDa), whereas the molecular mass of
the BSP-30-kDa protein, as the name implies, is 30,000
Da (Manjunath et al., 1987). BSP-A1 and BSP-A2 have the
same primary structure and differ only in extent of glyco-
sylation, and their mixture is also referred to as PDC-109
(Esch et al., 1983). Collectively, these four proteins are
referred to as bovine seminal plasma proteins, or BSP
proteins (Desnoyers and Manjunath, 1992). In this study,
the mixture of BSP-A1 and BSP-A2 has been used without
separating the glycosylated and unglycosylated forms of the
protein, and therefore the term PDC-109 will be used to
refer to it.
Biochemical studies have shown that the interaction of
BSP proteins with spermatozoa is mediated by their inter-
action with specific phospholipids, in particular with the
zwitterionic phospholipid, phosphatidylcholine (Desnoyers
and Manjunath, 1992). The interaction of PDC-109 with
spermatozoa leads to the efflux of choline phospholipids
and cholesterol from the sperm plasma membrane (referred
to as cholesterol efflux), which appears to be an important
step in the capacitation process (The´rien et al., 1998; Mo-
reau et al., 1999). The single polypeptide chain of PDC-109
consists of two tandemly repeating fibronectin type II do-
mains, each of which contains a choline phospholipid bind-
ing site, and both the binding sites are necessary for induc-
ing lipid efflux (Esch et al., 1983; Desnoyers and
Manjunath, 1992, 1993; Moreau et al., 1998). Because
capacitation is a necessary event before fertilization can
occur, it is important to understand the interaction of this
protein with sperm cell membranes to understand the mo-
lecular events involved in the capacitation process. Most
importantly, such an understanding potentially can lead to
the development of novel anti-fertility drugs.
Not only from the biological point of view, but also from
a biophysical perspective, the BSP proteins are of great
interest. Phosphatidylcholines (or the sphingolipid analog,
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sphingomyelin) are the major phospholipid component of
mammalian cell membranes. It is generally assumed that
these zwitterionic phospholipids play a passive structural
role as the major building blocks in biological membranes,
without any specific interactions. Our own results on lipid-
protein interactions with both integral and peripheral mem-
brane proteins generally indicate a lack of specific interac-
tions with phosphatidylcholine (reviewed in Marsh and
Horva´th, 1998). In view of the ubiquitous nature of phos-
phatidylcholines (or sphingomyelin) in mammalian mem-
branes, the identification of proteins that specifically inter-
act with these particular phospholipids is of great interest
and potential importance. This is not solely from a structural
and functional standpoint, but also with regard to the pos-
sibility that pathologies might occur arising from specific
protein or peptide interactions with this major membrane
constituent.
In the work described here, we have characterized the
interaction of PDC-109 with phosphatidylcholine mem-
branes in detail by using spin-label ESR spectroscopy. We
have particularly concentrated on the influence of the pro-
tein on the lipid chain mobility and on the membrane
chain-melting transition, on the penetration of the protein
into the membrane and its direct interaction with the lipid
chains, and on the specificity of interaction with particular
lipid species by using spin-labeled lipids with different
polar headgroups.
MATERIALS AND METHODS
Materials
Phosphorylcholine chloride (Ca2 salt), choline chloride, and Tris base
were from Sigma (St. Louis, MO). Sephadex G-50 (superfine), DEAE
Sephadex A-25, and DEAE Sephadex A-50 were obtained from Pharmacia
Biotech (Uppsala, Sweden). DMPC was obtained from Avanti Polar Lipids
(Alabaster, AL). The spin-labeled fatty acids and phosphatidylcholines
(n-PCSLs) were synthesized according to procedures outlined in Marsh
and Watts (1982). Spin-labeled phospholipids with different polar head-
groups (14-PGSL, 14-PESL, and 14-PSSL) were prepared from spin-
labeled phosphatidylcholine (14-PCSL) by phospholipase D-catalyzed
headgroup exchange, as described in the same reference. Spin-labeled
N-acyl phosphatidylethanolamine, 14-NAPESL, with the spin label in the
N-acyl chain was synthesized as described by Swamy et al. (2000). Spin-
labeled sphingomyelin (14-SMSL) was prepared as described by Hoff-
mann et al. (2000). Cholestane spin label (CSL) and androstanol spin label
(ASL) were obtained from Syva (Palo Alto, CA).
Samples of bovine semen and extraction
of BSP proteins
Samples of bovine semen, freshly collected from Ongole bulls with the aid
of an artificial vagina, were kindly provided by the Department of Animal
Reproduction, Acharya N. G. Ranga University of Agricultural Sciences,
Hyderabad, and Lam Farm, Department of Animal Breeding of the same
university at Guntur, Andhra Pradesh, India. The samples were stored on
ice, for a maximum of 9 h (until they were brought to the laboratory) and
then centrifuged at 3000 rpm in a refrigerated centrifuge to separate sperm
cells and seminal plasma. Total proteins from the seminal plasma were
precipitated by adding cold ethanol, and the precipitated proteins were
dissolved in distilled water and lyophilized. The lyophilized protein frac-
tion was delipidated by extraction with a mixture of n-butanol/di-isopro-
pylether (40/60; v/v), as described by Desnoyers and Manjunath (1993).
Purification of PDC-109
PDC-109 was purified by a modification of the procedure reported by
Calvete et al. (1996). In the modified procedure, delipidated BSP protein
fraction obtained according to the procedure of Desnoyers and Manjunath
(1992, 1993) was used instead of the bovine seminal plasma used by
Calvete et al. (1996). The delipidated BSP protein fraction was dissolved
in 50 mM Tris buffer, 0.15 M NaCl, 5 mM EDTA, pH 7.4 (TBS-I) and
subjected to gel filtration on a column of Sephadex G-50 superfine (2.5 
170 cm), preequilibrated with 50 mM Tris, 1.0 M NaCl, 5 mM EDTA, pH
6.4 (TBS-II). The major peak containing PDC-109 was collected, dialyzed
against TBS-II, and loaded onto a column of DEAE Sephadex A-25,
pre-equilibrated with the same buffer. After washing the column with
TBS-II buffer until no protein was found in the washings, the bound protein
was eluted with 100 mM choline chloride in the same buffer. The eluted
protein was dialyzed extensively against TBS-I to remove the choline
chloride, concentrated by lyophilization, and then dialyzed again against
the same buffer and stored at 4°C. Alternatively, the protein was lyophi-
lized to a powder and stored at 	20°C. Both types of sample were found
to bind to phosphatidylcholine membranes, or to DEAE Sephadex A-25,
without any noticeable decrease in the activity over several months of
storage. Purity of PDC-109 was assessed by SDS-PAGE (Laemmli, 1970)
where the protein moved as two closely spaced bands of Mr  13 kDa.
Gels of 10% or 12% acrylamide were routinely used.
Binding of PDC-109 to DMPC and
DMPC/cholesterol mixtures
The binding of PDC-109 to DMPC multilamellar vesicles and to DMPC
MLVs containing 25 mol % cholesterol was investigated by turbidimetry.
The lipid/lipid mixture was dissolved in CH2Cl2, and aliquots correspond-
ing to 1.0 mg of lipid each were transferred to glass test tubes and the
solvent was removed in a nitrogen gas stream. After removing the traces of
solvent by vacuum desiccation for over 3 h, the lipid film was hydrated
with 1.0 ml of 10 mM Hepes, 1 mM EDTA, 0.15 M NaCl, pH 7.4 buffer
(HBS), or with different amounts of protein solution in the same buffer. An
appropriate volume of buffer was added in the latter case to make up the
volume to 1.0 ml. The samples were warmed to 30°C and were mildly
vortexed several times and then subjected to 10 freeze-thaw cycles to get
a homogenous suspension. Alternately, samples were prepared by first
hydrating the lipid film with HBS, followed by the addition of PDC-109
and 10 freeze-thaw cycles. Turbidity of the samples was measured at 330
nm in a Shimadzu UV-3101PC UV-Vis-NIR double beam spectrometer
using 1-cm-path-length cells. Essentially similar results were obtained with
both methods of sample preparation.
The PDC-109/DMPC recombinants of high protein/lipid ratio (P/L 
2.0 w/w) were further analyzed by gel filtration on Sepharose CL6B (cf.
Moreau and Manjunath, 1999). The gel filtration column (1.7  50 cm)
was equilibrated with HBS and calibrated with standards with Mr values in
the range of 60,000 to 2  106 Da. Fractions were monitored by checking
absorption at 280 nm for protein and 330 nm for turbidity.
Electron spin resonance spectroscopy
ESR spectra were recorded on a Varian E-12 Century Line 9-GHz ESR
spectrometer. Samples were placed in 100-l glass capillaries and flame
sealed. The capillaries were placed in a standard 4-mm quartz sample tube
containing light silicone oil for thermal stability. The temperature of the
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sample was maintained constant by blowing thermostatted nitrogen gas
through a quartz dewar. Spectra were recorded using the following instru-
mental settings: scan width, 100 G; scan time, 4 min; time constant, 0.25 s;
modulation amplitude, 1.25 G; incident power, 10 mW. Values of the outer
hyperfine splitting, 2Amax, were determined by measuring the difference
between the low-field maximum and the high-field minimum. The error in
measuring the position of the maximum and minimum is 0.1–0.3 G
depending on the degree of motional line broadening; therefore the overall
error in the estimation of 2Amax is 0.2–0.6 G. Spectral subtractions were
performed essentially as described by Marsh (1982), using a program
written by Dr. Jo¨rg H. Kleinschmidt. Reference spectra for the motionally
restricted components were selected from a library of spectra of 14-PCSL
bound to the proteolipid protein from bovine myelin, recorded at different
temperatures. Reference spectra for the fluid components were chosen
from a library of spectra obtained by recording the ESR spectra of 1 mol
% 14-PCSL in egg PC at different temperatures. Subtraction end points
were established by overlaying the difference spectrum with the matching
fluid reference spectrum. To improve precision, the spectra were expanded
vertically in the outer wings. Uncertainty in the determination of the end
point is in the region of 
0.02–0.05, and this corresponds also to the
repeatability of determinations of the subtraction factor, f. This estimate
does not include the systematic error associated with imperfections in the
match with the reference spectra.
Sample preparation
Samples for ESR spectroscopy were prepared as follows. The lipid and 1
mol % of the spin label were co-dissolved in CH2Cl2, and a thin film of the
lipid was produced by evaporating the solvent with dry nitrogen gas. Final
traces of solvent were removed by subjecting the sample to vacuum
desiccation for at least 3 h. The sample was then hydrated with 100 l of
HBS buffer and vortexed. The lipid suspension thus obtained was trans-
ferred into a 100-l glass capillary and pelleted in a tabletop centrifuge.
Excess supernatant was removed and the capillary was flame-sealed.
Samples containing protein-lipid complex were prepared in a similar
manner except that the lipid film was hydrated directly with the protein
solution in HBS and subjected to at least five freeze-thaw cycles before
transferring to the glass capillaries. It was found that the samples contain-
ing protein could no longer be pelleted, and therefore the sample was used
as such for ESR studies. In view of this limitation, the volume of protein
solution added was minimized by using a high concentration protein (30
mg/ml), such that the amount of sample in the ESR cavity was maximized.
Protein assay
Protein concentrations were determined by the method of Lowry et al.
(1951) using bovine serum albumin as the standard. The concentration of
purified PDC-109 was estimated from its extinction coefficient at 280 nm
of 2.5 for a 1 mg/ml sample concentration (Calvete et al., 1996).
RESULTS
Lipid turbidity and binding of PDC-109
to DMPC membranes
Preliminary experiments on the binding of PDC-109 to
multilamellar vesicles of DMPC indicated that binding re-
sults in a partial solubilization of the vesicles as could be
observed by a decrease of the sample turbidity. Therefore,
binding and solubilization were monitored by measuring
turbidity of the samples at a wavelength of 330 nm. Fig. 1
gives the results of binding experiments where the turbidity
of MLVs of DMPC as well as DMPC:cholesterol (3:1;
mol/mol) was monitored as a function of the protein/lipid
(P/L) ratio. From this figure it is seen that the sample
turbidity decreases very little at low P/L ratios (up to0.75
P/L weight ratio), both for DMPC as well as for DMPC:
cholesterol (3:1; mol/mol). However, as the P/L ratio is
increased further, the sample turbidity decreases steeply up
to a P/L weight ratio of 1.5 and then decreases more
gradually as the P/L ratio is increased further. The results
obtained were qualitatively very similar irrespective of
whether the lipid film was directly hydrated with the protein
solution or protein solution was added to the prehydrated
lipid dispersion. Very similar results were obtained with
DMPC membranes containing 25 mol % cholesterol, except
that the decrease in absorbance was less steep and achieved
a limiting low value at rather higher protein content (2:1
w/w) (see Fig. 1). In view of these observations, a 2:1 P/L
weight ratio was chosen for the ESR spectral studies. Fur-
thermore, to investigate the effect of protein binding on the
lipid chain-melting phase transition, membranes made up of
DMPC alone were used, as this lipid gives a well-defined
gel-fluid phase transition.
Effect of binding of PDC-109 on lipid phase
transition and acyl chain dynamics
ESR spectra of phosphatidylcholine spin-labeled at the C-5
position of the sn-2 chain (5-PCSL) in DMPC membranes,
FIGURE 1 Binding of PDC-109 to DMPC multilamellar vesicles and
DMPC:cholesterol mixture, monitored by turbidimetry. The samples were
prepared by directly hydrating 1.0 mg of the lipid with an appropriate
amount of the protein and making up the volume to 1.0 ml. The samples
were then subjected to 10 freeze-thaw cycles, and the turbidity was
measured spectrophotometrically at 330 nm. Temperature  30°C.
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in the absence and in the presence of 2:1 (w/w) ratio of
added PDC-109, are shown in Fig. 2. The spectra recorded
in the absence of protein (dashed lines) exhibit an abrupt
change in the line shapes and outer hyperfine splittings
(2Amax) at 24°C, resulting from the increase in lipid chain
mobility at the chain-melting phase transition. Those re-
corded in the presence of PDC-109 (solid lines) do not show
any such abrupt changes; the changes observed in the ESR
spectra of the PDC-109-bound sample with increasing tem-
perature are more gradual. ESR spectra of 5-PCSL in
DMPC membranes at 28°C show a progressive increase in
outer hyperfine splitting with increasing PDC-109/DMPC
ratios up to2:1 (w/w) and then remain essentially constant
(data not shown). This behavior is consistent with the bind-
ing stoichiometry extrapolated from the steep change in
turbidity that is shown in Fig. 1.
Temperature dependences of the outer hyperfine split-
ting, 2Amax, for 5-PCSL in DMPC membranes, in the pres-
ence and in the absence of a 2:1 (w/w) ratio of PDC-109, are
given in Fig. 3. It is clearly seen from this figure that the
chain-melting phase transition, which is indicated for
DMPC membranes alone by an abrupt decrease in the value
of 2Amax at 23°C, is strongly perturbed by the binding of
PDC-109. At any given temperature, the outer hyperfine
splitting is consistently higher in the presence than in the
absence of PDC-109. This indicates that the protein inter-
acts with DMPC membranes in both the gel and fluid
phases.
Positional dependence of lipid chain perturbation
by PDC-109
To investigate whether the binding of PDC-109 to DMPC
membranes is accompanied by the interaction of the protein
with the hydrophobic interior of the lipid membrane, that is,
to investigate whether the protein or a part of it inserts into
the interior of the lipid bilayer, ESR studies were performed
with spin-labeled phosphatidylcholines, n-PCSL, bearing
the nitroxide spin label at different positions down the sn-2
acyl chain of the lipid. The ESR spectra of different posi-
tional isomers of phosphatidylcholine, in DMPC mem-
branes and in samples containing 2:1 (w/w) ratio of added
PDC-109, recorded at 0°C in the gel phase region of hy-
drated DMPC, are given in Fig. 4. From these spectra it is
evident that in the gel phase, protein binding decreases the
mobility of the lipid chains of DMPC at all positions up to
the 14th C atom.
ESR spectra of n-PCSL in dispersions of DMPC alone
and in samples containing PDC-109, recorded at 28°C,
corresponding to the liquid-crystalline phase of the host
lipid, are given in Fig. 5. Whereas the ESR spectra of the
spin-labels at positions close to the headgroup (n 5 and 8)
are broadened by protein binding, possibly indicating the
presence of overlapping components, those that are closer to
FIGURE 2 ESR spectra of the phosphatidylcholine spin label, 5-PCSL,
bearing the nitroxide moiety at the C-5 position of the sn-2 acyl chain, in
DMPC membranes in the presence and absence of PDC-109 (lipid:protein,
1:2 w/w). Solid lines correspond to spectra recorded from DMPC/PDC-109
recombinants, and dashed lines correspond to the spectra recorded from
DMPC membranes alone. The temperature at which the spectra were
recorded is indicated in the figure. The spectral width is 100 G.
FIGURE 3 Temperature dependence of the outer hyperfine splitting,
2Amax, for the 5-PCSL spin label in DMPC membranes (E) and in DMPC/
PDC-109 recombinants (F).
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the methyl end of the chain (n  12 and 14) clearly consist
of two components. Notably, the spectrum of 14-PCSL
closely resembles the spectra obtained with integral trans-
membrane proteins that have been reconstituted into lipid
membranes (see, e.g., Marsh and Horva´th, 1998). One com-
ponent in this spectrum is similar to the fluid lipid spectrum
(shown by the dashed line). The second component (re-
solved in the outer wings of the spectrum) has a much larger
outer hyperfine splitting, 2Amax, and represents a lipid pop-
ulation whose acyl chains are in direct contact with the
protein.
A plot of the values of 2Amax as a function of chain-
labeling position, obtained for the phosphatidylcholine spin
labels, n-PCSL, in membranes of DMPC alone and in
DMPC/PDC-109 recombinants (corresponding to the mo-
tionally restricted component, where the lines could be
resolved) at 28°C, is given in Fig. 6. Whereas the values of
2Amax obtained for the lipid membranes alone decrease as
the spin-label position is moved down the sn-2 chain of the
lipid, thus displaying the chain flexibility gradient charac-
teristic of fluid lipid membranes, the values of 2Amax for the
motionally restricted component remain approximately con-
stant, and are consistently larger, throughout the chain.
These observations further substantiate the interpretation
given above that PDC-109 penetrates into the hydrophobic
interior of the lipid membrane and interacts directly with the
acyl chains.
Interaction of PDC-109 with different spin-labeled
lipid species
To investigate the selectivity of PDC-109 for different lip-
ids, DMPC vesicles containing 1 mol % of different phos-
pholipid spin label species bearing the nitroxide moiety in
the sn-2 acyl chain at the 14th C atom were prepared. In
addition, samples were also prepared with probe amounts of
two steroid-based spin labels, the cholestane spin label and
the androstanol spin label. ESR spectra of the membrane
samples in the presence and in the absence of the protein
were recorded in the fluid-phase region of the lipid. A
comparison of the spectra obtained in the presence of PDC-
109 and in its absence, recorded at 28°C, is given in Fig. 7.
From this figure it is seen that, as for 14-PCSL, all the
spectra obtained in the presence of PDC-109 are composed
of two components. There is a fluid-like component, which
is similar to that of the spin label in lipid membranes alone,
and another component that corresponds to a more motion-
ally restricted spin-label population. The relative amounts
FIGURE 4 ESR spectra of phosphatidylcholine spin labels, n-PCSL, at
0°C in the gel phase of DMPC membranes, in the presence and absence of
PDC-109 (lipid:protein, 1:2 w/w). Dotted lines correspond to spectra
recorded from DMPC membranes alone, and solid lines correspond to the
spectra recorded from DMPC membranes in the presence of PDC-109.
Arrows indicate the outer hyperfine splitting, 2Amax. The spectral width is
100 G.
FIGURE 5 ESR spectra of phosphatidylcholine spin labels, n-PCSL, at
28°C in the fluid phase of DMPC membranes, in the presence and absence
of PDC-109 (lipid:protein, 1:2 w/w). Dotted lines correspond to spectra
recorded from DMPC membranes alone, and solid lines correspond to the
spectra recorded from DMPC membranes in the presence of PDC-109.
Arrows indicate the outer hyperfine splitting, 2Amax. The spectral width is
100 G.
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of these two components differ between the different lipid
species, reflecting the selectivity of interaction with the
PDC-109 protein.
The two components in the ESR spectra of different spin
labels obtained in the presence of PDC-109 can be resolved
by spectral subtraction and the contribution of each compo-
nent to the overall spectrum quantified. This is shown in
Fig. 8 for several of the spin labels in a DMPC host matrix,
in the presence of a 2:1 weight ratio of added PDC-109. The
spin label in each set of spectra is indicated on the right. In
each set of four spectra the top pair correspond to the
composite spectrum from the lipid-protein complex (solid
line) and an ESR spectrum matching the motionally re-
stricted component alone (dotted line). The lower pair of
spectra in each set of spectra corresponds to the fluid
component obtained from subtraction (solid line) and a
matching fluid spectrum (dotted line). The relative amounts
of the motionally restricted components (fraction, f) for the
different spin-labeled lipids in a DMPC host matrix in the
presence of PDC-109 are given in Table 1. These values
correspond to the fraction of the total double-integrated
intensity that must be subtracted from the composite first-
derivative spectrum of the PDC-109/lipid complex to obtain
the fluid-component end point. Note that the spectra in Fig.
8 are all normalized to the same maximum line height, and
therefore the difference spectra do not reflect their true
relative intensities.
DISCUSSION
Considering the fact that PDC-109 induces efflux of choline
phospholipids and cholesterol from spermatozoa by binding
to them upon ejaculation, the molecular mechanism of this
process is of great interest. Especially, because this lipid
efflux from spermatozoa promotes capacitation, a clear un-
derstanding of the efflux of phosphatidylcholine and cho-
lesterol mediated by PDC-109 could potentially lead to the
development of new anti-fertility drugs. In view of this, in
the present study we have characterized the interaction of
PDC-109 with phosphatidylcholine membranes by using
turbidity measurements and spin-label ESR spectroscopy.
Further, the lipid selectivity of this protein has been inves-
tigated in some detail by using spin-labeled analogs of
different phospholipids and steroid derivatives.
Solubilization of DMPC membranes by PDC-109
As seen from Fig. 1, binding of PDC-109 to DMPC MLVs
resulted in a decrease in the sample turbidity, indicating that
the size of the lipid assemblies is decreased upon protein
FIGURE 6 Positional dependence of the outer hyperfine splitting, 2Amax,
for phosphatidylcholine spin labels, n-PCSL, in DMPC membranes (E)
and in DMPC/PDC-109 (lipid:protein, 1:2 w/w) recombinants (F), at 28°C
in the fluid phase. The data given for n  12 and 14 in DMPC/PDC-109
recombinants correspond to the motionally restricted component of the
two-component spectra.
FIGURE 7 ESR spectra of different phospholipid spin labels, 14-XXSL,
bearing the spin label on the 14th C atom of the sn-2 chain, as well as the
cholestane spin label (CSL) and androstanol spin label (ASL), in the fluid
phase of DMPC membranes (  ) and of DMPC/PDC-109 (lipid:protein,
1:2 w/w) recombinants (——). Phospholipid spin labels are: 14-PCSL
(phosphatidylcholine), 14-PGSL (phosphatidylglycerol), 14-SMSL (sphin-
gomyelin), 14-PESL (phosphatidylethanolamine), 14-PSSL (phosphatidyl-
serine), and 14-NAPESL (N-acyl phosphatidylethanolamine). Spectra were
recorded at 28°C. The spectral width is 100 G.
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binding. Gel filtration on Sepharose CL6B gave an apparent
mass of 1.3  106 Da for the particles obtained upon
binding of PDC-109 to DMPC MLVs. Recent experiments
by Manjunath and co-workers (The´rien et al., 1997, 1998)
indicate that PDC-109 and other BSP proteins promote
sperm capacitation by removal of cholesterol and choline
phospholipids from sperm plasma membrane. The lipid
efflux particles resulting from binding of PDC-109 to hu-
man fibroblasts (a cell model used to study the lipid efflux)
were shown to be made up of BSP proteins, cholesterol, and
choline-containing phospholipids, with a size of 80 nm
(Moreau and Manjunath, 1999). Our observations indicate
that most probably the binding of PDC-109 to DMPC
MLVs also leads to the formation of such particles. Efflux
of choline phospholipids and cholesterol would then be
linked to the ability of BSP proteins to partially solubilize
PC-containing lipid membranes.
The results presented in Fig. 1 show that, in addition to
MLVs of DMPC alone, DMPC MLVs containing 25 mol %
cholesterol are also solubilized by PDC-109 at high P/L
ratios. The threshold required for complete solubilization,
however, is higher. Calvete and co-workers (Gasset et al.,
2000) have shown that the leakage of internal contents from
DOPC unilamellar vesicles that is induced by PDC-109
becomes considerably reduced in the presence of choles-
terol. Whereas there are certain parallels between these two
sets of results, they refer to very different types of experi-
ments. The work here concerns the fragmentation of very
large MLVs into smaller particles. That of Gasset et al.
(2000) involves the permeability/leakage of small, 90-nm-
diameter, unilamellar vesicles.
Stoichiometry of PDC-109/DMPC interaction
Fig. 1 represents the titration of DMPC dispersions with
PDC-109. Because DMPC was hydrated with the protein-
containing solution, all lipid is available for interaction with
PDC-109. Extrapolating the steeply changing part of the
turbidity to the quasi-saturation level yields a protein/lipid
stoichiometry of 1.7 w/w, i.e., a mole ratio of 11
DMPCs per PDC-109. For comparison, fluorescence titra-
tion of PDC-109 with small unilamellar DMPC vesicles
yielded a stoichiometry of 12 DMPCs/PDC-109 (Gasset
et al., 2000). A corresponding fluorescence titration with
PC, also in 2:1 mixtures with phosphatidylethanolamine or
phosphatidylserine, yielded a stoichiometry of 10 PCs/
PDC-109 (Mu¨ller et al., 1998). Note that in both these latter
cases, the PDC-109/PC ratios used in the titration were
beyond that at which a drastic decrease of particle size is
indicated in Fig. 1. The ESR spectra of PC with a short (five
C atoms) sn-2 chain bearing the nitroxide on the 4th C atom
were found to contain a motionally restricted component
with a stoichiometry of 11 PCs/PDC-109 (Mu¨ller et al.,
1998). Evidently, in this study, the spin labels of all the PCs
with short sn-2 chain with which PDC-109 interacts contact
the protein more or less directly.
FIGURE 8 Representative spectral subtractions for 14-position spin la-
bels. Spectra of 14-PCSL, 14-SMSL, 14-PGSL, and 14-PSSL in DMPC/
PDC-109 complexes are shown. In each set of four spectra the upper pair
correspond to the composite spectrum of the PDC-109/lipid complex
(——) and the motionally restricted component spectrum (  ) that is used
for subtraction from the composite spectrum. The lower pair of spectra
correspond to the subtraction result (——) and a matching fluid lipid
reference spectrum (  ). The spin label used for obtaining the spectrum of
the PDC-109 lipid complex in each case is indicated in the figure. Spectra
are all (including difference spectra) displayed normalized to the same
maximum line height.
TABLE 1 Fraction (f) of motionally restricted spin-labeled
lipid and relative association constants, Kr, normalized to that
for phosphatidylcholine (Kr
PC ) obtained from spectral
subtractions with the ESR spectra of different spin labels in
DMPC/PDC-109 complexes
Spin label
Temperature
(°C)
Motionally restricted
fraction (f) Kr/KrPC
14-PASL (pH 8.5) 28 0.55 1.38
14-PCSL 28 0.47 1.0
14-SMSL 28 0.47 1.0
14-PASL (pH 6.0) 28 0.46 0.96
14-PGSL 28 0.35 0.61
14-PSSL 28 0.35 0.61
14-NAPESL 28 0.21 0.30
14-PESL 28 0.23 0.34
ASL 32 0.35 0.61
The P/L ratio for all the samples was 2 (w/w). The f values are subject to
an error of 
0.02–0.05 due to uncertainties in the spectral subtractions.
For CSL, the motionally restricted spectral component was too small to
quantify reliably.
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Simple volumetric estimates show that a compact glob-
ular protein of molecular weight 13 kDa and partial specific
volume 0.7 cm3/g has a cross-sectional area in the range
of 6–7.5 nm2. A protein of this size would therefore
interact with 10–12 DMPC molecules (cross-sectional
area 0.6 nm2) at the membrane surface. These estimates
therefore suggest that the PDC-109/PC binding stoichiom-
etries found experimentally correspond approximately to
complete coverage of the membrane surface by the protein.
Membrane penetration by PDC-109
The spectra given in Figs. 4 and 5 show that binding of
PDC-109 to DMPC membranes affects the mobility of the
acyl chains up to the 14th C atom in the gel phase as well
as in the fluid phase, although the changes observed in the
fluid phase are certainly more marked. In particular, the
spectra of the spin labels bearing the nitroxide moiety at
positions close to the chain methyl terminus (12-PCSL and
14-PCSL) show two components in the fluid phase, indi-
cating a direct interaction between the protein and the
spin-labeled chain segment. Also, the outer peaks in the
spectra of 5-PCSL at 36°C and 44°C in Fig. 2 are asym-
metric. This suggests that the spectra are two-component
even up to this position of chain labeling. The spectral
resolution is not so good for 5-PCSL, however, because of
the larger outer hyperfine splitting of the fluid component,
relative to that for 12-PCSL or 14-PCSL. These results all
indicate that the protein, or a part of it, inserts into the
membrane interior upon binding and comes into direct
contact with the lipid chains. The reduction in cooperativity
of the lipid packing that is associated with abolition of the
chain-melting phase transition (see Fig. 3) is also consistent
with this conclusion.
The extent of motional restriction of the lipid chains by
PDC-109 is also a significant indicator of the nature of the
protein-lipid interaction. The value of the outer hyperfine
splitting for 14-PCSL at 28°C is relatively large: 2Amax 
59.5 G (see Fig. 6). This can be compared with correspond-
ing values obtained previously for 14-position labels inter-
acting with membrane-penetrant sections of different pe-
ripheral and integral proteins (Marsh and Horva´th, 1998).
The value of 2Amax for PDC-109 is considerably greater
than those for the peripheral membrane proteins apocyto-
chrome c (2Amax 49.5 G) and myelin basic protein (2Amax
 53.0 G). It is closer to those for the integral proteins,
myelin proteolipid protein (2Amax  62.8 G) and cyto-
chrome c oxidase (2Amax  60.9 G; Knowles et al., 1979).
A rather intimate association of the lipid chains with PDC-
109 is therefore implied. This is rather unusual for a soluble
protein that recognizes the lipid headgroup in a specific
manner (cf. Swamy and Marsh, 1997), and PDC-109 could
be unique in this respect. Because PDC-109 undergoes a
conformational change upon binding to DMPC membranes
(Gasset et al., 1997), it appears likely that the initial step in
the membrane binding by PDC-109 is the recognition of the
phosphorylcholine headgroup of choline phospholipids by
the protein, resulting in a conformational change, ultimately
leading to the penetration of the protein segments into the
hydrophobic interior of the membrane. The biexponential
kinetics of the binding reaction as observed by Mu¨ller et al.
(1998) is consistent with this model.
At saturation binding of PDC-109 (i.e., 2:1 w/w), approx-
imately half of the spin-labeled phosphatidylcholines are
motionally restricted directly by PDC-109 (see Table 1).
This corresponds to a rather low lipid/protein stoichiometry
of 5–6 mol/mol. Evidently, only part of the PDC-109
protein penetrates the membrane. Approximately 26 lipids
could be accommodated around the perimeter of the protein
in a compact globular form, if it is transmembrane (see
Marsh 1997), but half this number if it penetrates the
membrane only partially. Additionally, it is possible that the
protein is partially aggregated at saturation binding, which
would further reduce the intramembrane perimeter accessi-
ble to lipid. The stoichiometry of 11 motionally restricted
lipids found by Mu¨ller et al. (1998) at high lipid/protein
ratio that was mentioned already is possibly relevant in this
connection.
Relation to protein structure
In this section we attempt to identify those parts of the
protein sequence that are most likely to penetrate the mem-
brane. This is done by standard hydropathy analysis, but
using two separate scales corresponding to the interfacial
region and hydrophobic core of the membrane, respectively
(see White and Wimley, 1999).
Fig. 9 gives the free energy, averaged over a sliding
window of seven residues, for transfer of PDC-109 to the
interfacial region of the membrane (solid line). Individual-
residue transfer free energies are those determined by White
and Wimley (1999). Regions of this length whose transfer is
energetically favorable are indicated by the horizontal solid
lines in Fig. 9. These regions are contained within the two
FnII domains and constitute a considerable part of the
protein. The corresponding hydropathy profile for transfer
from the interfacial region of the membrane to the hydro-
phobic core is indicated by the dashed lines. Even for
relatively short seven-residue regions, a substantially
smaller portion of the protein is predicted to penetrate the
hydrophobic regions of the membrane than partitions to the
membrane interface. This is in agreement with the relatively
low stoichiometry of motionally restricted lipids that is
detected by spin-label ESR.
When the size of the window is increased to nine residues
or more, no sections of the protein with this length are
predicted to have transfer free energies that favor a location
in the hydrophobic core of the membrane. A similar situa-
tion was found for the myelin basic protein (Sankaram et al.,
1989). No very extended hydrophobic stretches are present
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in the sequence of this latter protein, although a motionally
restricted lipid population was detected on binding to neg-
atively charged lipids. As might be expected from the
above, no transmembrane sections are predicted for PDC-
109 with a window length of 19 residues. However, ener-
getically favorable transfer is still predicted to the mem-
brane interface: for the sections of the protein consisting of
residues 43–76 and 82–100. This relatively strong propen-
sity of the protein to partition to the membrane interface will
certainly potentiate penetration of the hydrophobic core by
shorter sections of the protein within these regions (see Fig. 9).
Of course, FnII domains could not be situated in the
interfacial region of the membrane in their entirety if PDC-
109 maintains its solution conformation on binding to lipid.
However, solution NMR studies of the second FnII domain
of PDC-109 and the homologous first FnII domain of fi-
bronectin (Constantine et al., 1992; Pickford et al., 1997)
have shown that five of the highly conserved clusters of
aromatic amino acid residues in these domains form a
solvent-exposed hydrophobic surface. It is therefore likely
that this surface, which constitutes the binding site for
collagen, is also that which binds to lipid membranes.
Penetration of these hydrophobic side chains into the mem-
brane may also, at least in part, be responsible for the direct
immobilization of the lipid chains that we observe by ESR
spectroscopy.
To summarize, candidate regions of the sequence for
which penetration of the hydrophobic core of the membrane
is energetically favorable are restricted to the FnII domains,
because the N-terminal region outside these domains bears
the acidic residues. Candidate penetrant sequences are short,
seven residues or less, and are indicated by the horizontal
dashed bars in Fig. 9. The net transfer free energies are
favorable but relatively small and therefore are probably
insufficient to ensure tight binding of the protein. The latter
is presumably determined by interfacial interactions and the
specific interaction with the headgroups of choline-contain-
ing phospholipids. The situation is somewhat analogous to
that of the myelin basic protein (Sankaram et al., 1989) and
apocytochrome c (Go¨rrissen et al., 1986; Marsh, 2001).
Both these proteins partially penetrate negatively charged
lipid membranes but are displaced from the membrane at
high ionic strength.
Lipid selectivity
A clear pattern of selectivity in interaction of PCD-109 with
different lipid species is evident from Table 1. The lipid
affinity can be expressed thermodynamically in terms of the
association constants, Kr, for interaction of the different
spin-labeled lipids with PDC-109, relative to the back-
ground DMPC host lipid. The experimentally determined
fractions, f, of motionally restricted lipid depend directly on
these relative association constants. Normalized relative to
the value, KrPC, for spin-labeled phosphatidylcholine, the
relative association constants are given by (Marsh, 1985):
Kr /KrPC 1/ fPC 1 /1/ f 1, (1)
where fPC (0.47) is the fraction of motionally restricted
14-PCSL. These values of Kr/ KrPC are also listed in Table 1.
Equation 1 is derived from the equation for equilibrium
lipid-protein association, taking into account the fact that
the lipid/protein ratio is the same for all samples.
Based on the data given in Fig. 7 and Table 1, the lipid
selectivity of PDC-109 is in the following order: phospha-
tidic acid (pH 8.5)  phosphatidylcholine  sphingomye-
lin  phosphatidic acid (pH 6.0)  phosphatidylglycerol 
phosphatidylserine  androstanol  phosphatidylethanol-
amine  N-acyl phosphatidylethanolamine  cholestane.
Though the highest selectivity is seen for phosphatidic acid
dianion, the physiologically irrelevant pH of 8.5 where it is
seen coupled with the fact that phosphatidic acid is normally
present only at very low concentrations in normal mem-
branes makes this observation less important. The selectiv-
ity observed for the phosphocholine-containing lipids, phos-
phatidylcholine and sphingomyelin, is the highest among
other lipids for their interaction with PDC-109. This is a
highly unusual situation compared with spin-label results
obtained on the selectivity of lipid interactions with integral
membrane proteins (Marsh and Horva´th, 1998). In the latter
case, although the selectivity of interaction is not solely
electrostatic in origin, the highest selectivities are obtained
for anionic lipids. Neither phosphatidylcholine nor sphin-
FIGURE 9 Hydropathy profile for PDC-109 (Bra¨uer and Scheit, 1991),
calculated with the interfacial (——) and octanol minus interfacial
(— — —) hydrophobicity scales of White and Wimley (1999). Plotted is
the free energy of transfer from water to the membrane interface (——)
and from the interface to the hydrophobic core of the membrane (———),
by using a seven-residue window. Solid and dashed horizontal lines rep-
resent energetically favorable regions for transfer to the membrane inter-
face (IF) and to the hydrophobic core (oct-IF), respectively. Dotted hori-
zontal lines designate the two FnII domains.
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gomyelin display a preferential interaction with any of the
integral proteins studied. Also, peripheral membrane pro-
teins do not interact preferentially with phosphatidylcholine
(Sankaram and Marsh, 1993).
The selectivity pattern that emerges from Table 1 is
consistent with the findings of Desnoyers and Manjunath
(1992), who investigated the selectivity with a more limited
range of lipid species. Their studies involved the binding to
lipids coated on plastic plates, as opposed to the lipid probes
in bilayer membranes used in the present study. Also, the
selectivity for phosphatidylcholine over phosphatidylserine
and phosphatidylethanolamine found here is consistent with
the attenuation of binding to PC vesicles containing admix-
tures of these latter two lipids that was observed by Mu¨ller
et al. (1998).
The results obtained with the steroid probes, ASL and
CSL, deserve comment in view of the involvement of BSP
proteins in cholesterol efflux (The´rien et al., 1998, 1999).
We find that PDC-109 exhibits considerable selectivity for
the ASL. This is a sterol analog that contains the 17-OH
group attached to the steroid nucleus. On the other hand, the
CSL in which the 3-OH group of the cholesterol structure
is replaced by the nitroxide doxyl moiety is very poorly
recognized by the protein. This suggests that the hydroxy
group of cholesterol is important for the recognition by the
protein, whereas the alkyl tail at the 17-position is not
particularly relevant for this interaction. In this connection,
it should be noted that spin-labeled androstanol displays an
affinity for the nicotinic acetylcholine receptor like that of
cholesterol (Ellena et al., 1983) and interacts with the poly-
ene antibiotic amphotericin in a manner similar to that of
cholesterol (Aracava et al., 1981).
CONCLUSIONS
The ESR results presented in this study demonstrate that
PDC-109 binds to phospholipid membranes by specific
interaction with choline phospholipids. The binding results
in an immobilization of the lipid acyl chains and also
solubilizes multilamellar liposomes made up of PC and of
PC/cholesterol. Although PDC-109 exhibits the highest se-
lectivity for the choline phospholipids (PC and SM), it also
shows considerable selectivity for other phospholipids such
as phosphatidylglycerol and phosphatidylserine. The dis-
tinctly higher selectivity observed for the ASL as opposed
to the CSL shows that the hydroxyl group of the sterol plays
a crucial role in the interaction of the steroid with PDC-109
and hence could be important in the process of cholesterol
efflux. The specific recognition of PC and SM by PDC-109
is a significant result because the zwitterionic lipids PC,
phosphatidylethanolamine, and SM have long been consid-
ered to play a passive structural role in biological mem-
branes. The present results demonstrate that the phospho-
rylcholine moiety of PC (or the sphingolipid analog SM)
can be specifically recognized by proteins, and such recog-
nition can mediate biologically important processes such as
cholesterol efflux from the sperm cell membranes. It would
be interesting to see whether there are other choline-binding
proteins in nature that recognize PC/SM in their interaction
with biological membranes.
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